NCT01739244View on ClinicalTrials.gov

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Ocular HypertensionOpen Angle Glaucoma
Interventions
DRUG

SYL040012

Ocular topical administration of SYL040012 for 14 consecutive days

DRUG

Placebo

Ocular topical administration of placebo for 14 consecutive days

Trial Locations (11)

10138

East Tallin Central Hospital, Tallinn

13419

Eye Clinic Dr. Krista Turman, Tallinn

28034

Hospital Universitario Ramón y Cajal, Madrid

28040

Hospital Universitario Clínico San Carlos, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

31008

Clinica Universidad Navarra, Pamplona

47011

Instituto de Oftalmobiología Aplicada, Valladolid

50937

Uniklinik Köln, Cologne

55131

Universitaetsklinikum Mainz, Mainz

79106

Universitaetsklinikum Freiburg, Freiburg im Breisgau

08022

Institut Català de Retina, Barcelona

All Listed Sponsors
lead

Sylentis, S.A.

INDUSTRY

NCT01739244 - Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma | Biotech Hunter | Biotech Hunter